Impaired Hemorheology in Exacerbations of COPD

Table 5

The RBC aggregation measurements of the groups.

	Control group ( = 12)	Newly diagnosed patient group		Exacerbation group; ( = 16)
		Before treatment; ( = 13)	After treatment; ( = 13)
AMP (au)	25.0 ± 2.91	25.1 ± 3.90	24.65 ± 3.18		0.002	0.002
AI (%)	68.15 ± 5.90	72.33 ± 6.16	73.16 ± 8.17		0.0001	0.007
(sn)	1.79 ± 0.55	1.45 ± 0.55	1.39 ± 0.68		0.001	0.003

Values are expressed as means ± SD; AMP: amplitude of aggregation; AI: aggregation index; : aggregation half time. : difference between the control group, before treatment of newly diagnosed COPD, and the exacerbation group; : difference between the control group, after treatment of newly diagnosed COPD, and the exacerbation group; < 0.05: difference from control, < 0.05: difference from before treatment of COPD, and < 0.05: difference from after treatment of COPD.